COXSACKIEVIRUS B BLEND MONOCLONAL ANTIBODIES— 510(k) K940471

Substantially Equivalent

Chemicon Intl., Inc.

FDA 510(k) clearance K940471 for COXSACKIEVIRUS B BLEND MONOCLONAL ANTIBODIES, Substantially Equivalent on 1995-09-08. Applicant: Chemicon Intl., Inc..

Clearance details

Applicant: Chemicon Intl., Inc.
Product code: Code GNM
Advisory panel: Microbiology
Date received: 1994-02-02
Decision date: 1995-09-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Temecula, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.